Global Anti-Obesity Therapeutics Market Research Report 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 109

Report ID: 6365

Anti-obesity drugs are the drugs that help in reducing or controlling body mass, either by decreasing the craving or increasing the consumption of calories. Appetite control is achieved through the use of agonists for appetite suppressing pathways.
Geographically, North America captures the largest market share on account of increasing obese population. As per the historical trends, more than one-third of the U.S. population is obese. However, Asia Pacific is anticipated to grow at the fastest rate due to increasing demand for the drugs and awareness about the risk associated with obesity. According to WHO, 13.0% of the population were obese in 2014. In developing countries the rate of childhood obesity is increasing and has been 30.0% higher than that of developed countries.

The global Anti-Obesity Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Anti-Obesity Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Obesity Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Bristol-Myers Squibb
Eisai Company
FlaxoSithKline plc.
Novo Nordisk
Alizyme
BoehringerIngelheim GmbH
Pfizer
Takeda Pharmaceutical
Rhythm Pharmaceuticals
Shionogi USA
Vivus
Zafgen
Norgine Pharmaceuticals Ltd.

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Centrally Acting Anti-obesity Drugs
Peripherally Acting Anti-obesity Drugs

Segment by Application
Hospital Use
Clinic Use
Household
Other

Table of Contents

Executive Summary
1 Anti-Obesity Therapeutics Market Overview
1.1 Product Overview and Scope of Anti-Obesity Therapeutics
1.2 Anti-Obesity Therapeutics Segment by Type
1.2.1 Global Anti-Obesity Therapeutics Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Centrally Acting Anti-obesity Drugs
1.2.3 Peripherally Acting Anti-obesity Drugs
1.3 Anti-Obesity Therapeutics Segment by Application
1.3.1 Anti-Obesity Therapeutics Consumption Comparison by Application (2014-2025)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Household
1.3.5 Other
1.4 Global Anti-Obesity Therapeutics Market by Region
1.4.1 Global Anti-Obesity Therapeutics Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Anti-Obesity Therapeutics Market Size
1.5.1 Global Anti-Obesity Therapeutics Revenue (2014-2025)
1.5.2 Global Anti-Obesity Therapeutics Production (2014-2025)

2 Global Anti-Obesity Therapeutics Market Competition by Manufacturers
2.1 Global Anti-Obesity Therapeutics Production Market Share by Manufacturers (2014-2019)
2.2 Global Anti-Obesity Therapeutics Revenue Share by Manufacturers (2014-2019)
2.3 Global Anti-Obesity Therapeutics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Anti-Obesity Therapeutics Production Sites, Area Served, Product Types
2.5 Anti-Obesity Therapeutics Market Competitive Situation and Trends
2.5.1 Anti-Obesity Therapeutics Market Concentration Rate
2.5.2 Anti-Obesity Therapeutics Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Anti-Obesity Therapeutics Production Market Share by Regions
3.1 Global Anti-Obesity Therapeutics Production Market Share by Regions
3.2 Global Anti-Obesity Therapeutics Revenue Market Share by Regions (2014-2019)
3.3 Global Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Anti-Obesity Therapeutics Production
3.4.1 North America Anti-Obesity Therapeutics Production Growth Rate (2014-2019)
3.4.2 North America Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Anti-Obesity Therapeutics Production
3.5.1 Europe Anti-Obesity Therapeutics Production Growth Rate (2014-2019)
3.5.2 Europe Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Anti-Obesity Therapeutics Production (2014-2019)
3.6.1 China Anti-Obesity Therapeutics Production Growth Rate (2014-2019)
3.6.2 China Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Anti-Obesity Therapeutics Production (2014-2019)
3.7.1 Japan Anti-Obesity Therapeutics Production Growth Rate (2014-2019)
3.7.2 Japan Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Anti-Obesity Therapeutics Consumption by Regions
4.1 Global Anti-Obesity Therapeutics Consumption by Regions
4.2 North America Anti-Obesity Therapeutics Consumption (2014-2019)
4.3 Europe Anti-Obesity Therapeutics Consumption (2014-2019)
4.4 China Anti-Obesity Therapeutics Consumption (2014-2019)
4.5 Japan Anti-Obesity Therapeutics Consumption (2014-2019)

5 Global Anti-Obesity Therapeutics Production, Revenue, Price Trend by Type
5.1 Global Anti-Obesity Therapeutics Production Market Share by Type (2014-2019)
5.2 Global Anti-Obesity Therapeutics Revenue Market Share by Type (2014-2019)
5.3 Global Anti-Obesity Therapeutics Price by Type (2014-2019)
5.4 Global Anti-Obesity Therapeutics Production Growth by Type (2014-2019)

6 Global Anti-Obesity Therapeutics Market Analysis by Applications
6.1 Global Anti-Obesity Therapeutics Consumption Market Share by Application (2014-2019)
6.2 Global Anti-Obesity Therapeutics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Anti-Obesity Therapeutics Business
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Anti-Obesity Therapeutics Production Sites and Area Served
7.1.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.1.3 Bristol-Myers Squibb Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Eisai Company
7.2.1 Eisai Company Anti-Obesity Therapeutics Production Sites and Area Served
7.2.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.2.3 Eisai Company Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 FlaxoSithKline plc.
7.3.1 FlaxoSithKline plc. Anti-Obesity Therapeutics Production Sites and Area Served
7.3.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.3.3 FlaxoSithKline plc. Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Novo Nordisk
7.4.1 Novo Nordisk Anti-Obesity Therapeutics Production Sites and Area Served
7.4.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.4.3 Novo Nordisk Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Alizyme
7.5.1 Alizyme Anti-Obesity Therapeutics Production Sites and Area Served
7.5.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.5.3 Alizyme Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 BoehringerIngelheim GmbH
7.6.1 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production Sites and Area Served
7.6.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.6.3 BoehringerIngelheim GmbH Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Pfizer
7.7.1 Pfizer Anti-Obesity Therapeutics Production Sites and Area Served
7.7.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.7.3 Pfizer Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Takeda Pharmaceutical
7.8.1 Takeda Pharmaceutical Anti-Obesity Therapeutics Production Sites and Area Served
7.8.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.8.3 Takeda Pharmaceutical Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Rhythm Pharmaceuticals
7.9.1 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production Sites and Area Served
7.9.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.9.3 Rhythm Pharmaceuticals Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Shionogi USA
7.10.1 Shionogi USA Anti-Obesity Therapeutics Production Sites and Area Served
7.10.2 Anti-Obesity Therapeutics Product Introduction, Application and Specification
7.10.3 Shionogi USA Anti-Obesity Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served
7.11 Vivus
7.12 Zafgen
7.13 Norgine Pharmaceuticals Ltd.

8 Anti-Obesity Therapeutics Manufacturing Cost Analysis
8.1 Anti-Obesity Therapeutics Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Anti-Obesity Therapeutics
8.4 Anti-Obesity Therapeutics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Anti-Obesity Therapeutics Distributors List
9.3 Anti-Obesity Therapeutics Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Anti-Obesity Therapeutics Market Forecast
11.1 Global Anti-Obesity Therapeutics Production, Revenue Forecast
11.1.1 Global Anti-Obesity Therapeutics Production Growth Rate Forecast (2019-2025)
11.1.2 Global Anti-Obesity Therapeutics Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Anti-Obesity Therapeutics Price and Trend Forecast (2019-2025)
11.2 Global Anti-Obesity Therapeutics Production Forecast by Regions (2019-2025)
11.2.1 North America Anti-Obesity Therapeutics Production, Revenue Forecast (2019-2025)
11.2.2 Europe Anti-Obesity Therapeutics Production, Revenue Forecast (2019-2025)
11.2.3 China Anti-Obesity Therapeutics Production, Revenue Forecast (2019-2025)
11.2.4 Japan Anti-Obesity Therapeutics Production, Revenue Forecast (2019-2025)
11.3 Global Anti-Obesity Therapeutics Consumption Forecast by Regions (2019-2025)
11.3.1 North America Anti-Obesity Therapeutics Consumption Forecast (2019-2025)
11.3.2 Europe Anti-Obesity Therapeutics Consumption Forecast (2019-2025)
11.3.3 China Anti-Obesity Therapeutics Consumption Forecast (2019-2025)
11.3.4 Japan Anti-Obesity Therapeutics Consumption Forecast (2019-2025)
11.4 Global Anti-Obesity Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Anti-Obesity Therapeutics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer